HB Estate Developers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 1:41 pm

Quick Insight

HB Estate Developers Ltd, operating in the construction, contracting, and engineering industry, currently has an intrinsic value of 80.9 with a market capitalization of 174 Cr. The company's P/E ratio stands at 16.9, reflecting a moderate valuation, while its ROE and ROCE are at 6.60% and 8.20% respectively, indicating room for improvement in profitability. With a healthy operating profit margin of 27.53%, the company has shown efficiency in cost management. However, the relatively low net profit of 11 Cr raises concerns about bottom-line performance. The company's high promoter holding of 71.98% suggests confidence from insiders, but the low institutional ownership warrants attention for potential market perception. With a manageable debt level of 284 Cr and a comfortable current ratio of 2.08x, HB Estate Developers Ltd appears financially stable, although the P/BV ratio of 1.24x indicates a slightly overvalued position. In conclusion, while the company shows stability and operational efficiency, efforts to enhance profitability and attract institutional investors could be key areas for future growth.

Competitors of HB Estate Developers Ltd

All Competitor Stocks of HB Estate Developers Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:55 pm

Below is a detailed analysis of the quarterly data for HB Estate Developers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 23.76 Cr.. The value appears to be declining and may need further review. It has decreased from 33.23 Cr. (Mar 2025) to 23.76 Cr., marking a decrease of 9.47 Cr..
• For Expenses, as of Jun 2025, the value is 17.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.97 Cr. (Mar 2025) to 17.22 Cr., marking a decrease of 2.75 Cr..
• For Operating Profit, as of Jun 2025, the value is 6.54 Cr.. The value appears to be declining and may need further review. It has decreased from 13.26 Cr. (Mar 2025) to 6.54 Cr., marking a decrease of 6.72 Cr..
• For OPM %, as of Jun 2025, the value is 27.53%. The value appears to be declining and may need further review. It has decreased from 39.90% (Mar 2025) to 27.53%, marking a decrease of 12.37%.
• For Other Income, as of Jun 2025, the value is 0.40 Cr.. The value appears to be declining and may need further review. It has decreased from 0.98 Cr. (Mar 2025) to 0.40 Cr., marking a decrease of 0.58 Cr..
• For Interest, as of Jun 2025, the value is 4.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.09 Cr. (Mar 2025) to 4.43 Cr., marking a decrease of 0.66 Cr..
• For Depreciation, as of Jun 2025, the value is 1.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.87 Cr. (Mar 2025) to 1.97 Cr., marking an increase of 0.10 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.54 Cr.. The value appears to be declining and may need further review. It has decreased from 7.28 Cr. (Mar 2025) to 0.54 Cr., marking a decrease of 6.74 Cr..
• For Tax %, as of Jun 2025, the value is 27.78%. The value appears to be improving (decreasing) as expected. It has decreased from 37.09% (Mar 2025) to 27.78%, marking a decrease of 9.31%.
• For Net Profit, as of Jun 2025, the value is 0.38 Cr.. The value appears to be declining and may need further review. It has decreased from 4.58 Cr. (Mar 2025) to 0.38 Cr., marking a decrease of 4.20 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.18. The value appears to be declining and may need further review. It has decreased from 2.13 (Mar 2025) to 0.18, marking a decrease of 1.95.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 8:34 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:07 pm

Below is a detailed analysis of the balance sheet data for HB Estate Developers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2024) to 22.00 Cr., marking an increase of 2.00 Cr..
• For Reserves, as of Mar 2025, the value is 153.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2024) to 153.00 Cr., marking an increase of 24.00 Cr..
• For Borrowings, as of Mar 2025, the value is 284.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 311.00 Cr. (Mar 2024) to 284.00 Cr., marking a decrease of 27.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 38.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.00 Cr. (Mar 2024) to 38.00 Cr., marking an increase of 4.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 496.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 494.00 Cr. (Mar 2024) to 496.00 Cr., marking an increase of 2.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 404.00 Cr.. The value appears to be declining and may need further review. It has decreased from 406.00 Cr. (Mar 2024) to 404.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 85.00 Cr. (Mar 2024) to 90.00 Cr., marking an increase of 5.00 Cr..
• For Total Assets, as of Mar 2025, the value is 496.00 Cr.. The value appears strong and on an upward trend. It has increased from 494.00 Cr. (Mar 2024) to 496.00 Cr., marking an increase of 2.00 Cr..

However, the Borrowings (284.00 Cr.) are higher than the Reserves (153.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for HB Estate Developers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has increased from 2.00 (Mar 24) to 5.31, marking an increase of 3.31.
• For Diluted EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has increased from 2.00 (Mar 24) to 5.31, marking an increase of 3.31.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.46. This value is within the healthy range. It has increased from 5.74 (Mar 24) to 8.46, marking an increase of 2.72.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 80.30. It has increased from 75.13 (Mar 24) to 80.30, marking an increase of 5.17.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 80.30. It has increased from 75.13 (Mar 24) to 80.30, marking an increase of 5.17.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 54.15. It has decreased from 55.44 (Mar 24) to 54.15, marking a decrease of 1.29.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 20.90. This value is within the healthy range. It has increased from 20.72 (Mar 24) to 20.90, marking an increase of 0.18.
• For PBIT / Share (Rs.), as of Mar 25, the value is 17.41. This value is within the healthy range. It has increased from 16.95 (Mar 24) to 17.41, marking an increase of 0.46.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.36. This value is within the healthy range. It has increased from 3.71 (Mar 24) to 7.36, marking an increase of 3.65.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.97. This value is within the healthy range. It has increased from 1.97 (Mar 24) to 4.97, marking an increase of 3.00.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.97. This value is within the healthy range. It has increased from 1.97 (Mar 24) to 4.97, marking an increase of 3.00.
• For PBDIT Margin (%), as of Mar 25, the value is 38.60. This value is within the healthy range. It has increased from 37.37 (Mar 24) to 38.60, marking an increase of 1.23.
• For PBIT Margin (%), as of Mar 25, the value is 32.14. This value exceeds the healthy maximum of 20. It has increased from 30.57 (Mar 24) to 32.14, marking an increase of 1.57.
• For PBT Margin (%), as of Mar 25, the value is 13.59. This value is within the healthy range. It has increased from 6.69 (Mar 24) to 13.59, marking an increase of 6.90.
• For Net Profit Margin (%), as of Mar 25, the value is 9.17. This value is within the healthy range. It has increased from 3.55 (Mar 24) to 9.17, marking an increase of 5.62.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.17. This value is within the healthy range. It has increased from 3.55 (Mar 24) to 9.17, marking an increase of 5.62.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 15. It has increased from 2.62 (Mar 24) to 6.18, marking an increase of 3.56.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.84. This value is below the healthy minimum of 10. It has increased from 7.81 (Mar 24) to 8.84, marking an increase of 1.03.
• For Return On Assets (%), as of Mar 25, the value is 2.17. This value is below the healthy minimum of 5. It has increased from 0.78 (Mar 24) to 2.17, marking an increase of 1.39.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.39. This value exceeds the healthy maximum of 1. It has increased from 1.11 (Mar 24) to 1.39, marking an increase of 0.28.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.63. This value exceeds the healthy maximum of 1. It has increased from 1.39 (Mar 24) to 1.63, marking an increase of 0.24.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.23. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1.5. It has increased from 0.60 (Mar 24) to 0.70, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has increased from 0.38 (Mar 24) to 0.49, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.71, marking an increase of 0.71.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.08. This value is below the healthy minimum of 3. It has increased from 1.57 (Mar 24) to 2.08, marking an increase of 0.51.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.49. This value is below the healthy minimum of 3. It has increased from 1.15 (Mar 24) to 1.49, marking an increase of 0.34.
• For Enterprise Value (Cr.), as of Mar 25, the value is 480.62. It has increased from 423.20 (Mar 24) to 480.62, marking an increase of 57.42.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.08. This value exceeds the healthy maximum of 3. It has increased from 3.87 (Mar 24) to 4.08, marking an increase of 0.21.
• For EV / EBITDA (X), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 10.35 (Mar 24) to 10.58, marking an increase of 0.23.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.83, marking an increase of 0.70.
• For Price / BV (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 0.83 (Mar 24) to 1.24, marking an increase of 0.41.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.83, marking an increase of 0.70.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness